Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow NovelStem International Corp.

Get SEC filing alerts via email and in your feed for NovelStem International Corp.

NSTM

NovelStem International Corp.

About NovelStem International Corp.

NovelStem International Corp. is a holding company focused on biotech investments, primarily owning interests in NewStem Ltd., an Israeli biotech developing stem cell-based diagnostics and therapeutics, and a joint venture in entertainment properties. The company’s core activities involve managing biotech assets, licensing technology, and pursuing innovative medical research. It relies on investments and strategic partnerships, with a focus on advancing regenerative medicine and cancer diagnostics.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from NovelStem International Corp.

1
1
NovelStem International Corp. NovelStem International Corp. Reports Improved Financial Results with Reduced Losses in Q1 2026

Via official filing (AI summary) | 20 days ago | 0 comments

2
1
NovelStem International Corp. NovelStem International Corp. Reports Net Income Turnaround to $2.38 Million for Fiscal Year 2025

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
NovelStem International Corp. NovelStem International Corp. Reports Net Income Turnaround and Significant Expense Reduction for Nine Months Ended September 30, 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
NovelStem International Corp. NovelStem International Corp. Reports $2.55M Net Income for Six Months Ended June 30, 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
NovelStem International Corp. NovelStem International Corp. Reports Q1 2025 Financial Results with Reduced Net Loss and Ongoing Liquidation Efforts

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
NovelStem International Corp. NovelStem International Corp. Reports $3.2 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
NovelStem International Corp. NovelStem International Corp. Reports Decline in Assets, Improvement in Losses Amid Challenges

Via official filing (AI summary) | over 1 year ago | 0 comments